KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on... (spects of the Company. Such statements ...)

KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10-K

Date:6/22/2009

spects of the Company. Such statements may be identified by the use of words like "plan," "expect," "aim," "believe," "project," "anticipate," "commit," "intend," "estimate," "will," "should," "could" and other expressions that indicate future events and trends.

All statements that address expectations or projections about the future, including without limitation, product development, product launches, regulatory approvals, market position, acquisitions, sale of assets, revenues, expenditures, resumption of manufacturing and distribution of products and the impact of the recall and suspension of shipments on revenues, and other financial results, are forward-looking statements.

All forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the "safe harbor" provisions, the Company provides the following cautionary statements identifying important economic, political and technological factors, which among others, could cause actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

Such factors include (but are not limited to) the following: (1) the ability to continue as a going concern; (2) changes in the current and future business environment, including interest rates and capital and consumer spending; (3) the difficulty of predicting FDA approvals, including timing, and that any period of exclusivity may not be realized; (4) the possibility of not obtaining FDA approvals or delay in obtaining FDA approvals; (5) acceptance and demand for new pharmaceutical products; (6) the introduction and impact of competitive products and pricing, including as a result of so-called authorized-generic drugs; (7) new product development and launch, including the possibility that any product launch may be delayed or that product acceptance may be less than anticipated; (8) reliance on ke
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance

Post Your Comments:

(Date:5/25/2013)... Sun City Center, FL (PRWEB) May 25, 2013 ... years, is one of many of the NALA’s businesses throughout ... Owner, Craig Amshel chose to participate in the nationwide event ... served as a Lieutenant Colonel in the Army. He said, ... work in the community I serve, but I live here ...

(Date:5/25/2013)... New York,NY (PRWEB) May 25, 2013 ... SizeItUp officially declared the integration of the 2012 ... Lamborghini Aventador is the latest entrant in the list ... Designed intelligently, the vehicle is all set to thrill ... with vicious acceleration power and spectacular looks, the 2012 ...

(Date:5/25/2013)... (PRWEB) May 25, 2013 Dr. Farooq ... surgery clinic in Dubai, has announced his practice’s adoption ... is the only FDA-cleared femtosecond laser proven with more ... safety and precision of LASIK. , “We are happy ... Advanced Femtosecond Laser at our Dubai LASIK practice,” Ashraf ...

(Date:5/25/2013)... IBISWorld estimates that revenue for the Cell ... of 28.7% to $1.0 billion in the five years to ... 2008, no new cell therapy products were introduced, according to ... that period. In the years since, however, the Food and ... contributed to the industry's fast growth during the five years ...

(Date:5/25/2013)... (PRWEB) May 25, 2013 Ayurveda ... Ayurveda means "knowledge or wisdom of life". While a medical ... and the transformation of consciousness. Its fundamental philosophy is that ... with our environment. It believes that in order to re-establish ... of harmony and then adopt a life style which brings ...

Breaking Medicine News(10 mins):Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2 Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2 Health News:Atlanta Vision Clinic Acquires the Latest in Blade-Free Lasik Technology Bringing Dubai Patients the Intralase Method 2 Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2 Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3 Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2

[0] Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event [0] Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador [0] Atlanta Vision Clinic Acquires the Latest in Blade-Free Lasik Technology Bringing Dubai Patients the Intralase Method [0] Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld [0] Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes

... ... and best-selling author Mary Shomon is launching a new campaign to help promote public awareness ... well as a free downloadable ebook, a Youtube video, and a Facebook social networking page. ... (PRWEB) January 12, ...

... HARRISBURG, Pa. , Jan. 12 Capital BlueCross is ... of have been resolved for former Turbine Airfoil Designs (TAD) employees ... its premiums and subsequently went out of business. , Last ... paying its health insurance premiums since October, and that their coverage ...

... , , WEST PALM ... Healthcare & Medical Tourism Conference Korea ( http://www.asiamedicaltourismcongress.com ) will ... a joint initiative between the Medical Tourism Association (MTA) and ... of the emerging leading destinations for medical tourism and global ...

... Number of Donors Continues Organization,s Role of Leading OPO in U.S. ... Jr. waited over four years for one phone call – a ... Boris was placed on the heart transplant waiting list in late 2004 ... arrived on April 25, 2009 , thanks to the generosity of ...

... symptoms occur, researchers say , TUESDAY, Jan. 12 ... is more accurate than some other commonly used ... symptoms, according to U.S. researchers. , So-called "paraneoplastic ... breast, ovarian and other types of cancer when ...

... 50 adds to likelihood of diagnosis, study finds , TUESDAY, ... who had pancreatic cancer before age 50 face a greatly ... , Researchers already knew that people with several relatives diagnosed ... develop the disease, but it wasn,t clear whether the relatives, ...

It's January...Do You Know Where Your Thyroid Is? Thyroid Awareness Month Focuses on Millions of Undiagnosed Americans with Thyroid Problems Capital BlueCross and Local Providers Reach Solution for Health Care Claims of Former Turbine Airfoil Designs Employees Global Healthcare & Medical Tourism Conference Korea Announced for April 13-16th, 2010 Gift of Life Breaks National Record for Life-Saving Organ Donations Combo PET-CT Scans Can Spot Hidden Cancers With Pancreatic Cancer, Age Factors Into Familial Risk

(Date:5/24/2013)... -- The potential of the pulmonary route ... agents has been receiving undeniable attention with the recent ... The crucial formulation considerations for orally inhaled products together ... role in the efficiency of pulmonary delivery, and great ... formulation techniques and devices in recent years. ...

(Date:5/23/2013)... PARÍS, 24 de mayo de 2013 Volcano ... desarrollador y fabricante de herramientas de precisión para ... tratamiento de la enfermedad vascular periférica y coronaria, ... ( Ad enosine V asodilator I ... durante la sesión de ensayo clínico hot line ...

(Date:5/23/2013)... Nephros, Inc. (OTC Bulletin Board: ... develops and sells high performance liquid purification ultrafilters, announced ... addition, the concurrent temporary reduction in exercise price for ... 2013. Nephros estimates that it will receive ... A portion of the proceeds will be used for ...

Breaking Medicine Technology:Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6 Nephros Announces Completion of Rights Offering 2 Nephros Announces Completion of Rights Offering 3 Nephros Announces Completion of Rights Offering 4

[0] Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany [0] Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 [0] Nephros Announces Completion of Rights Offering

... 18, 2012 UCB, Inc., a leading biopharmaceutical company ... severe central nervous system and immunological disorders, is marking ... reinforcing its commitment to improving the lives of patients ... this year,s DDW meeting. "DDW is ...

... The new arthroscopy simulator ArthroS trains orthopedic surgeons for ... The Swiss company VirtaMed AG is launching ArthroS™, a ... get the chance to practice different operations numerous times ... as pilots improve their skills on flight simulators. ArthroS™ ...

Cached Medicine Technology:UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 2 UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 3 UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 4 Swiss Engineering for Surgical Perfection 2 Swiss Engineering for Surgical Perfection 3

UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 Swiss Engineering for Surgical Perfection

... a new standard in QPCR with the ... system offers superior performance, more flexibility, and ... system - with Windows 98SE and Pentium ... Premier Sound Speakers, Surge Protector (US only), ...

... The LightCycler System is the ... The LightCycler System enables you to ... 30 min, and simultaneously quantify and ... during amplification. The unique Melting Curve ...

... ABI PRISM 7900HT Sequence Detection System ... that detects and quantitates nucleic acid ... 384-well plate capability make the 7900HT ... high-throughput requirements of todays drug discovery ...

Sealing Mat for 96-well, 2.0ml, Deep Well, Square Available Sterile...

Medicine Products:

Mx4000 Multiplex Quantitative PCR System LightCycler Instrument ABI PRISM 7900HT Sequence Detection System 96-well, Deep Well Plate Sealing Mat